Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 525

1.

Do certain atypical antipsychotics increase the risk of diabetes? A critical review of 17 pharmacoepidemiologic studies.

Ramaswamy K, Masand PS, Nasrallah HA.

Ann Clin Psychiatry. 2006 Jul-Sep;18(3):183-94. Review.

PMID:
16923657
[PubMed - indexed for MEDLINE]
2.

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.

Newcomer JW.

CNS Drugs. 2005;19 Suppl 1:1-93. Review.

PMID:
15998156
[PubMed - indexed for MEDLINE]
3.

Atypical antipsychotics and glucose homeostasis.

Bergman RN, Ader M.

J Clin Psychiatry. 2005 Apr;66(4):504-14. Review.

PMID:
15816794
[PubMed - indexed for MEDLINE]
4.

Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database.

Gianfrancesco FD, Grogg AL, Mahmoud RA, Wang RH, Nasrallah HA.

J Clin Psychiatry. 2002 Oct;63(10):920-30.

PMID:
12416602
[PubMed - indexed for MEDLINE]
5.

Antipsychotic exposure and type 2 diabetes among patients with schizophrenia: a matched case-control study of California Medicaid claims.

Lambert BL, Chou CH, Chang KY, Tafesse E, Carson W.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):417-25.

PMID:
15786516
[PubMed - indexed for MEDLINE]
6.

Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis.

Henderson DC, Cagliero E, Copeland PM, Borba CP, Evins E, Hayden D, Weber MT, Anderson EJ, Allison DB, Daley TB, Schoenfeld D, Goff DC.

Arch Gen Psychiatry. 2005 Jan;62(1):19-28.

PMID:
15630069
[PubMed - indexed for MEDLINE]
7.

The influence of study design on the results of pharmacoepidemiologic studies of diabetes risk with antipsychotic therapy.

Gianfrancesco F, Wang RH, Nasrallah HA.

Ann Clin Psychiatry. 2006 Jan-Mar;18(1):9-17.

PMID:
16517448
[PubMed - indexed for MEDLINE]
8.

Glucose metabolism in Japanese schizophrenia patients treated with risperidone or olanzapine.

Yasui-Furukori N, Sato Y, Furukori H, Saito M, Nakagami T, Kaneko S.

J Clin Psychiatry. 2009 Jan;70(1):95-100.

PMID:
19026267
[PubMed - indexed for MEDLINE]
9.

Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.

Lindenmayer JP, Czobor P, Volavka J, Citrome L, Sheitman B, McEvoy JP, Cooper TB, Chakos M, Lieberman JA.

Am J Psychiatry. 2003 Feb;160(2):290-6.

PMID:
12562575
[PubMed - indexed for MEDLINE]
10.

Differential effects of antipsychotic agents on the risk of development of type 2 diabetes mellitus in patients with mood disorders.

Gianfrancesco F, Grogg A, Mahmoud R, Wang RH, Meletiche D.

Clin Ther. 2003 Apr;25(4):1150-71.

PMID:
12809963
[PubMed - indexed for MEDLINE]
11.

A regional comparison of developing diabetes among VA patients exposed to typical and atypical antipsychotics relative to corticosteroids and proton pump inhibitors.

Barnett M, Argo T, Alexander B, Perry P.

Ann Clin Psychiatry. 2006 Jan-Mar;18(1):1-7.

PMID:
16517447
[PubMed - indexed for MEDLINE]
12.

[Therapy with antipsychotic drugs as a risk factor for diabetes in schizophrenia: a case-control study].

Rubio G, Gómez-de-la-Cámara A, Ledesma F, Burón JA, Rodríguez-Morales A, Martínez-Junquera G; Grupo Español para el Estudio de la Diabetes en Pacientes Esquizofrénicos.

Med Clin (Barc). 2006 Apr 1;126(12):441-4. Spanish.

PMID:
16620729
[PubMed - indexed for MEDLINE]
13.

Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.

Finkel S, Kozma C, Long S, Greenspan A, Mahmoud R, Baser O, Engelhart L.

Int Psychogeriatr. 2005 Dec;17(4):617-29. Epub 2005 Oct 5.

PMID:
16202186
[PubMed - indexed for MEDLINE]
14.

The effects of novel antipsychotics on glucose and lipid levels.

Wirshing DA, Boyd JA, Meng LR, Ballon JS, Marder SR, Wirshing WC.

J Clin Psychiatry. 2002 Oct;63(10):856-65.

PMID:
12416594
[PubMed - indexed for MEDLINE]
15.

Comparative study of the development of diabetes mellitus in patients taking risperidone and olanzapine.

Fuller MA, Shermock KM, Secic M, Grogg AL.

Pharmacotherapy. 2003 Aug;23(8):1037-43.

PMID:
12921249
[PubMed - indexed for MEDLINE]
16.

Assessment of antipsychotic-related risk of diabetes mellitus in a Medicaid psychosis population: sensitivity to study design.

Gianfrancesco F, Pesa J, Wang RH, Nasrallah H.

Am J Health Syst Pharm. 2006 Mar 1;63(5):431-41.

PMID:
16484517
[PubMed - indexed for MEDLINE]
17.

Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.

Østbye T, Curtis LH, Masselink LE, Hutchison S, Wright A, Dans PE, Schulman KA, Krishnan RR.

Pharmacoepidemiol Drug Saf. 2005 Jun;14(6):407-15.

PMID:
15372671
[PubMed - indexed for MEDLINE]
18.

Possible induction of mania or hypomania by atypical antipsychotics: an updated review of reported cases.

Rachid F, Bertschy G, Bondolfi G, Aubry JM.

J Clin Psychiatry. 2004 Nov;65(11):1537-45. Review.

PMID:
15554769
[PubMed - indexed for MEDLINE]
19.

Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients.

Citrome L, Jaffe A, Levine J, Allingham B, Robinson J.

Psychiatr Serv. 2004 Sep;55(9):1006-13.

PMID:
15345760
[PubMed - indexed for MEDLINE]
20.

Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia.

Sernyak MJ, Leslie DL, Alarcon RD, Losonczy MF, Rosenheck R.

Am J Psychiatry. 2002 Apr;159(4):561-6.

PMID:
11925293
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk